Press Release: Enzo : Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX
FARMINGDALE, N.Y., March 28, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (Enzo or the Company) today announced its intention to voluntarily delist its common stock from The New York Stock...
Read full article »
Enzo is a New York-based biotechnology company that develops diagnostics tests for the treatment of cancer, diabetes, HIV, uveitis, and inflammatory bowel diseases.
Read more